Fortress offers licences after COVID-19 testing patent backlash

Labrador Diagnostics, a subsidiary of Fortress Investment Group, has offered royalty-free licences to third parties for its patent-protected diagnostics technology, just days after suing US-based health startup BioFire, which is attempting to develop COVID-19 testing kits.

Already registered?

For multi-user price options, or to check if your company has an existing subscription that we can add you to for FREE, please email Adrian Tapping at atapping@newtonmedia.co.uk

More on this story

Americas

Labrador drops BioFire suit after COVID-19 revelation

30 June 2020 Labrador Diagnostics has dropped its controversial patent complaint against COVID-19 test developer BioMerieux.

Americas

COVID-19: patent procurement and licensing

31 March 2020 Jonathan Tietz, Jason Mock, and Kristel Schorr of Foley & Lardner offer their thoughts on patent procurement and licensing for COVID-19-related technologies.

Americas

Costa Rica asks WHO to create voluntary COVID-19 IP pool

26 March 2020 The Costa Rican government has asked the World Health Organization to create a voluntary pool to collect patent rights for technologies that are useful for the detection, prevention, control and treatment of the COVID-19 pandemic.

More on this story

Americas

Labrador drops BioFire suit after COVID-19 revelation

30 June 2020 Labrador Diagnostics has dropped its controversial patent complaint against COVID-19 test developer BioMerieux.

Americas

COVID-19: patent procurement and licensing

31 March 2020 Jonathan Tietz, Jason Mock, and Kristel Schorr of Foley & Lardner offer their thoughts on patent procurement and licensing for COVID-19-related technologies.

Americas

Costa Rica asks WHO to create voluntary COVID-19 IP pool

More on this story

Americas

Labrador drops BioFire suit after COVID-19 revelation

30 June 2020 Labrador Diagnostics has dropped its controversial patent complaint against COVID-19 test developer BioMerieux.

Americas

COVID-19: patent procurement and licensing

31 March 2020 Jonathan Tietz, Jason Mock, and Kristel Schorr of Foley & Lardner offer their thoughts on patent procurement and licensing for COVID-19-related technologies.

Americas

Costa Rica asks WHO to create voluntary COVID-19 IP pool